Skip to content
NT 20-F

Annual Report (Foreign)

China SXT Pharmaceuticals, Inc. SXTC

0001013762-24-003228

← back to feed
Filed
Jul 31, 2024 12:00 AM ET
Period of report
Late filing notice (Form 12b-25). The company has told the SEC it will miss this report's deadline — a recognized red flag. No financial statements are included.

On SEC.gov

Financials in this filing

Late-filing notices contain no financial statements. The actual report follows when the company files it.